Versatility of the mouse reversal/set-shifting test: Effects of topiramate and sex

Physiology and Behavior

Volumn 107, Issue 5, 2012, Pages 781-786

  Bissonette, Gregory B ^a,b   Lande, Michelle D ^a   Martins, Gabriela J ^a,b   Powell, Elizabeth M ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Attentional set shift; Female; GABA; Reversal learning; Topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; DISCRIMINATION LEARNING; FEMALE; LATENT PERIOD; LEARNING; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVERSAL SET SHIFTING TEST; SEX DIFFERENCE; TASK PERFORMANCE;

ANIMALS; ATTENTION; DISCRIMINATION LEARNING; FEMALE; FRUCTOSE; MALE; MICE; MICE, INBRED C57BL; REACTION TIME; REVERSAL LEARNING; SEX FACTORS;

EID: 84870654922     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.05.018     Document Type: Article

References (52)

1. Verte S., Geurts H.M., Roeyers H., Oosterlaan J., Sergeant J.A. Executive functioning in children with autism and Tourette syndrome. Dev Psychopathol 2005, 17:415-445.
2. Hill E.L. Executive dysfunction in autism. Trends Cogn Sci 2004, 8:26-32.
3. Pantelis C., Barber F.Z., Barnes T.R., Nelson H.E., Owen A.M., Robbins T.W. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 1999, 37:251-270.
4. Nelson H.E. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976, 12:313-324.
5. Berg E.A. A simple objective technique for measuring flexibility in thinking. J Gen Psychol 1948, 39:15-22.
6. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
7. Diaz-Arrastia R., Agostini M.A., Madden C.J., Van Ness P.C. Posttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis. Epilepsia 2009, 50(Suppl. 2):14-20.
8. Prentice K.J., Gold J.M., Buchanan R.W. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophr Res 2008, 106:81-87.
9. Mukhopadhyay P., Dutt A., Kumar Das S., Basu A., Hazra A., Dhibar T., et al. Identification of neuroanatomical substrates of set-shifting ability: evidence from patients with focal brain lesions. Prog Brain Res 2008, 168:95-104.
10. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 2006, 73:19-38.
11. Manes F., Sahakian B., Clark L., Rogers R., Antoun N., Aitken M., et al. Decision-making processes following damage to the prefrontal cortex. Brain 2002, 125:624-639.
12. Leeson V.C., Robbins T.W., Matheson E., Hutton S.B., Ron M.A., Barnes T.R., et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 2009, 66:586-593.
13. Dias R., Robbins T.W., Roberts A.C. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 1996, 110:872-886.
14. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 2000, 20:4320-4324.
15. McAlonan K., Brown V.J. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 2003, 146:97-103.
16. Bissonette G.B., Powell E.M. Reversal learning and attentional set-shifting in mice. Neuropharmacology 2012, 62:1168-1174.
17. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996, 380:69-72.
18. Bissonette G.B., Martins G.J., Franz T.M., Harper E.S., Schoenbaum G., Powell E.M. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 2008, 28:11124-11130.
19. Brigman J.L., Bussey T.J., Saksida L.M., Rothblat L.A. Discrimination of multidimensional visual stimuli by mice: intra- and extradimensional shifts. Behav Neurosci 2005, 119:839-842.
20. Colacicco G., Welzl H., Lipp H.P., Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav Brain Res 2002, 132:95-102.
21. Garner J.P., Thogerson C.M., Wurbel H., Murray J.D., Mench J.A. Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice. Behav Brain Res 2006, 173:53-61.
22. Schoenbaum G., Roesch M. Orbitofrontal cortex, associative learning, and expectancies. Neuron 2005, 47:1-4.
23. Clarke H.F., Walker S.C., Crofts H.S., Dalley J.W., Robbins T.W., Roberts A.C. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 2005, 25:532-538.
24. Bissonette G.B., Bae M.H., Suresh T., Jaffe D.E., Powell E.M. Astrocyte-mediated hepatocyte growth factor/scatter factor supplementation restores GABAergic interneurons and corrects reversal learning deficits in mice. J Neurosci 2010, 30:2918-2923.
25. Shank R.P., Gardocki J.F., Streeter A.J., Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000, 41(Suppl. 1):S3-S9.
26. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997, 28:167-179.
27. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000, 41(Suppl. 1):S17-S20.
28. Motamedi G., Meador K. Epilepsy and cognition. Epilepsy Behav 2003, 4(Suppl. 2):S25-S38.
29. Roy Chengappa K.N., Schwarzman L.K., Hulihan J.F., Xiang J., Rosenthal N.R. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2006, 67:1698-1706.
30. Blum D., Meador K., Biton V., Fakhoury T., Shneker B., Chung S., et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006, 67:400-406.
31. Hambrecht M., Maurer K., Hafner H. Evidence for a gender bias in epidemiological studies of schizophrenia. Schizophr Res 1993, 8:223-231.
32. Kerbeshian J., Peng C.Z., Burd L. Tourette syndrome and comorbid early-onset schizophrenia. J Psychosom Res 2009, 67:515-523.
33. Stone J.L., Merriman B., Cantor R.M., Yonan A.L., Gilliam T.C., Geschwind D.H., et al. Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet 2004, 75:1117-1123.
34. Floresco S.B., Magyar O., Ghods-Sharifi S., Vexelman C., Tse M.T. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 2006, 31:297-309.
35. Brooks S.P., Betteridge H., Trueman R.C., Jones L., Dunnett S.B. Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull 2006, 69:452-457.
36. Tunbridge E.M., Bannerman D.M., Sharp T., Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004, 24:5331-5335.
37. Kos T., Nikiforuk A., Rafa D., Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology (Berl) 2010, 214:911-921.
38. Glickstein S.B., Desteno D.A., Hof P.R., Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 2005, 15:1016-1024.
39. Brigman J.L., Padukiewicz K.E., Sutherland M.L., Rothblat L.A. Executive functions in the heterozygous reeler mouse model of schizophrenia. Behav Neurosci 2006, 120:984-988.
40. Laurent V., Podhorna J. Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task. Behav Pharmacol 2004, 15:141-148.
41. Egerton A., Reid L., McKerchar C.E., Morris B.J., Pratt J.A. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology (Berl) 2005, 179:77-84.
42. Schwabe K., Enkel T., Klein S., Schutte M., Koch M. Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour. Behav Brain Res 2004, 153:21-34.
43. Caligioni C.S. Assessing reproductive status/stages in mice. Curr Protoc Neurosci 2009, Appendix 4:Appendix 4I.
44. Meador K.J. Effects of topiramate on cognition. J Neurol Neurosurg Psychiatry 2001, 71:134-135.
45. Loring D.W., Williamson D.J., Meador K.J., Wiegand F., Hulihan J. Topiramate dose effects on cognition: a randomized double-blind study. Neurology 2011, 76:131-137.
46. Jung K.Y., Cho J.W., Joo E.Y., Kim S.H., Choi K.M., Chin J., et al. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials. Clin Neurophysiol 2010, 121:1494-1501.
47. Coppola G., Verrotti A., Resicato G., Ferrarelli S., Auricchio G., Operto F.F., et al. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav 2008, 12:253-256.
48. Jansen J.F., Aldenkamp A.P., Marian Majoie H.J., Reijs R.P., de Krom M.C., Hofman P.A., et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 2006, 9:181-185.
49. Brigman J.L., Ihne J., Saksida L.M., Bussey T.J., Holmes A. Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL/6J mice. Front Behav Neurosci 2009, 3:2.
50. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003, 23:622-631.
51. Uban K.A., Rummel J., Floresco S.B., Galea L.A. Estradiol modulates effort-based decision making in female rats. Neuropsychopharmacology 2012, 37:390-401.
52. O'Leary T.P., Savoie V., Brown R.E. Learning, memory and search strategies of inbred mouse strains with different visual abilities in the Barnes maze. Behav Brain Res 2011, 216:531-542.